Current place of high-dose irinotecan chemotherapy in patients with metastatic colorectal cancer

被引：0
作者：
Mohamed Hebbar
Marc Ychou
Michel Ducreux
机构：
[1] Centre Hospitalo-Universitaire,Unité d’Oncologie Médicale
[2] Val d’Aurelle Anti-Cancer Centre,Department of Digestive Oncology
[3] Gustave-Roussy Institute,Department of Digestive Oncology
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Colorectal cancer; Liver metastases; Irinotecan; UGT1A1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：749 / 752
页数：3
相关论文
共 50 条
  • [21] Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy:: Efficacy and prognostic factors
    Karaoglu, A
    Yalcin, S
    Tekuzman, G
    Kars, A
    Çelik, I
    Güler, N
    Özisik, Y
    Türker, A
    Barista, I
    Güllü, I
    TUMORI, 2003, 89 (02) : 141 - 145
  • [22] Chemotherapy for the Treatment of Patients with Metastatic Colorectal Cancer: An Overview
    William H. Isacoff
    Katrina Borud
    World Journal of Surgery, 1997, 21 : 748 - 762
  • [23] Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study
    Tewes, M
    Schleucher, N
    Achterrath, W
    Wilke, HJ
    Frings, S
    Seeber, S
    Harstrick, A
    Rustum, YM
    Vanhoefer, U
    ANNALS OF ONCOLOGY, 2003, 14 (09) : 1442 - 1448
  • [24] Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients
    E Rouits
    V Charasson
    A Pétain
    M Boisdron-Celle
    J-P Delord
    M Fonck
    A Laurand
    A-L Poirier
    A Morel
    E Chatelut
    J Robert
    E Gamelin
    British Journal of Cancer, 2008, 99 : 1239 - 1245
  • [25] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Aparicio, T
    Desramé, J
    Lecomte, T
    Mitry, E
    Belloc, J
    Etienney, I
    Montembault, S
    Vayre, L
    Locher, C
    Ezenfis, J
    Artru, P
    Mabro, M
    Dominguez, S
    BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1439 - 1444
  • [26] Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study
    Aranda, E.
    Valladares, M.
    Martinez-Villacampa, M.
    Benavides, M.
    Gomez, A.
    Massutti, B.
    Marcuello, E.
    Constenla, M.
    Camara, J. C.
    Carrato, A.
    Duenas, R.
    Reboredo, M.
    Navarro, M.
    Diaz-Rubio, E.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 251 - 257
  • [27] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    T Aparicio
    J Desramé
    T Lecomte
    E Mitry
    J Belloc
    I Etienney
    S Montembault
    L Vayre
    C Locher
    J Ezenfis
    P Artru
    M Mabro
    S Dominguez
    British Journal of Cancer, 2003, 89 : 1439 - 1444
  • [28] Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients
    Rouits, E.
    Charasson, V.
    Petain, A.
    Boisdron-Celle, M.
    Delord, J-P
    Fonck, M.
    Laurand, A.
    Poirier, A-L
    Morel, A.
    Chatelut, E.
    Robert, J.
    Gamelin, E.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1239 - 1245
  • [29] Irinotecan: New results in the combination chemotherapy of colorectal cancer
    Wilke, H
    Vanhoefer, U
    Achterrath, W
    Stahl, M
    ONKOLOGIE, 2000, 23 : S8 - S14
  • [30] Epidermal Growth Factor Receptor Expression Discrepancies in Metastatic Colorectal Cancer Patients Treated with Cetuximab Plus Irinotecan-Based Chemotherapy Refractory to Irinotecan and Oxaliplatin
    Han, Hye-Suk
    Chang, Hee Jin
    Hong, Yong Sang
    Kim, Sun Young
    Lee, Keun Seok
    Jung, Kyung Hae
    DISEASES OF THE COLON & RECTUM, 2009, 52 (06) : 1144 - 1151
12345